Clobazam recalls

The FDA has published 7 recalls involving Clobazam since 2019. The latest was reported on 22 Jan 2025. Most were for packaging defects. Breckenridge Pharmaceutical has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls7since 2019

Last 12 months0reported

Class I00% of total

Ongoing3latest 22 Jan 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 2Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 7 100%Class III 0 0%

Why clobazam is recalled

Companies

By year

2025229%
2024114%
2023229%
2022114%
2019114%

Ongoing clobazam recalls

3 active

Reported	Class	Recall	Company	Reason	Where
22 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
15 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
28 Feb 2024Drug	CLASS II	Clobazam Tablets 10mg recalled by Micro LabsClobazam	Micro Labs	Potency & Assay	Nationwide

All clobazam recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
22 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
15 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
28 Feb 2024Drug	CLASS II	Clobazam Tablets 10mg recalled by Micro LabsClobazam	Micro Labs	Potency & Assay	Nationwide
22 Mar 2023Drug	CLASS II	Clobazam Tablets, 20 mg, CIV recalled by Breckenridge Pharmaceutical	Breckenridge Pharmaceutical	Manufacturing (CGMP) Deviations	Nationwide
22 Mar 2023Drug	CLASS II	Clobazam Tablets, 10 mg, CIV recalled by Breckenridge Pharmaceutical	Breckenridge Pharmaceutical	Manufacturing (CGMP) Deviations	Nationwide
26 Jan 2022Drug	CLASS II	Clobazam Oral Suspension 5 mg/mL recalled by VistaPharm	VistaPharm	Potency & Assay	Nationwide
31 Jul 2019Drug	CLASS II	Clobazam Oral Suspension, 5 mg/mL recalled by BionpharmaClobazam	Bionpharma	Sterility	Nationwide

Should you stop taking Clobazam?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.